1 hour ago · Hong Kong
Ex-US FDA official to lead Hong Kong’s new medical products regulator
What's happening
SignalsMonitor is following this as a politics story. South China Morning Post Asia is the outlet attached so far. The reports are tied to Hong Kong. The first report grouped here was at 12 Oct 2026, 09:17 UTC. The headline in use is “Ex-US FDA official to lead Hong Kong’s new medical products regulator”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
A Beijing-educated former official at the US federal drug regulator has been appointed to lead Hong Kong’s new medical products body, tasked with accelerating the clinical use of medicines and medical devices as part of a regulatory overhaul. Li Zili, who previously worked at the US Food and Drug Administration…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
Ex-US FDA official to lead Hong Kong’s new medical products regulator
Reported by 1 outlet
- South China Morning Post
- South China Morning PostEx-US FDA official to lead Hong Kong’s new medical products regulator